Guizhou Yibai Pharmaceutical Co Ltd (600594) — Financial Flexibility Index
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥40.36 Million (operating CF CN¥33.28 Million minus capex CN¥7.08 Million) represents 0% of total liabilities (CN¥1.32 Billion). Also explore Guizhou Yibai Pharmaceutical Co Ltd (600594) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Guizhou Yibai Pharmaceutical Co Ltd across 24 annual periods. Check how strategically is Guizhou Yibai Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for Guizhou Yibai Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600594 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥291.70 Million | CN¥256.71 Million | CN¥1.17 Billion | ▲ +103.1% |
| 2024 | 0.12x | CN¥183.19 Million | CN¥86.87 Million | CN¥1.49 Billion | ▼ -61.9% |
| 2023 | 0.32x | CN¥507.99 Million | CN¥377.61 Million | CN¥1.58 Billion | ▼ -19.3% |
| 2022 | 0.40x | CN¥668.22 Million | CN¥345.30 Million | CN¥1.68 Billion | ▼ -56.6% |
| 2021 | 0.92x | CN¥1.38 Billion | CN¥934.21 Million | CN¥1.51 Billion | ▲ +112.3% |
| 2020 | 0.43x | CN¥762.40 Million | CN¥366.66 Million | CN¥1.76 Billion | ▲ +45.3% |
| 2019 | 0.30x | CN¥563.99 Million | CN¥362.71 Million | CN¥1.89 Billion | ▲ +42.5% |
| 2018 | 0.21x | CN¥535.62 Million | CN¥214.30 Million | CN¥2.56 Billion | ▼ -50.8% |
| 2017 | 0.42x | CN¥1.08 Billion | CN¥681.78 Million | CN¥2.55 Billion | ▲ +42.7% |
| 2016 | 0.30x | CN¥713.15 Million | CN¥380.62 Million | CN¥2.40 Billion | ▼ -29.6% |
| 2015 | 0.42x | CN¥861.70 Million | CN¥573.68 Million | CN¥2.04 Billion | ▲ +17.5% |
| 2014 | 0.36x | CN¥745.52 Million | CN¥541.58 Million | CN¥2.07 Billion | ▼ -46.3% |
| 2013 | 0.67x | CN¥850.72 Million | CN¥577.24 Million | CN¥1.27 Billion | ▼ -1.4% |
| 2012 | 0.68x | CN¥497.66 Million | CN¥288.01 Million | CN¥731.33 Million | ▲ +7.8% |
| 2011 | 0.63x | CN¥420.17 Million | CN¥277.83 Million | CN¥665.51 Million | ▲ +163.1% |
| 2010 | 0.24x | CN¥165.32 Million | CN¥115.66 Million | CN¥688.82 Million | ▼ -7.7% |
| 2009 | 0.26x | CN¥148.51 Million | CN¥103.88 Million | CN¥571.26 Million | ▼ -36.0% |
| 2008 | 0.41x | CN¥252.12 Million | CN¥189.26 Million | CN¥620.62 Million | ▲ +386.9% |
| 2007 | 0.08x | CN¥50.92 Million | CN¥11.94 Million | CN¥610.24 Million | ▼ -58.4% |
| 2006 | 0.20x | CN¥112.78 Million | CN¥95.77 Million | CN¥562.27 Million | ▲ +33.1% |
| 2005 | 0.15x | CN¥98.37 Million | CN¥17.38 Million | CN¥652.65 Million | ▼ -15.7% |
| 2004 | 0.18x | CN¥64.60 Million | CN¥-44.80 Million | CN¥361.10 Million | ▼ -81.2% |
| 2003 | 0.95x | CN¥261.57 Million | CN¥92.10 Million | CN¥274.93 Million | ▲ +73.4% |
| 2002 | 0.55x | CN¥95.96 Million | CN¥73.46 Million | CN¥174.87 Million | — |